Advertisement Grey Market Drugs Rule Western European Pharmacy Industry: Pfizer - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Grey Market Drugs Rule Western European Pharmacy Industry: Pfizer

Fake drugs valued at EUR10.5bn are sold in Europe every year, and Germany and Italy are found to be the key consumers of these drugs, reported a research funded by Pfizer, whose products Viagra and Lipitor are among the key targets for fakers.

The ‘Cracking Counterfeit Europe’ study sought out information from 14,000 people in 14 countries with regard to any purchases of prescription-only medicines made without a prescription. The results showed that average of 21% had made the kind of purchases, the figure surging to 38% in Germany and Italy.

EU industry commissioner noted that 34 million fake pills were forfeited at customs points during a course of two months in 2009. According to European Alliance for Access to Safe Medicines (EAASM), over and above the smuggling, as many as two-thirds of the drugs bought online were fake or of inferior quality.

According to Reuters, the contribution of weight-loss medicines is nearly half of all online drug transactions, followed by prescription treatments for pills for erectile dysfunction, smoking cessation drugs, flu, and painkillers. Around 1 in 5 people in the continent have bought medicines online.

Jim Thomson, chairman of the EAASM, told Reuters: “Counterfeit medicine is costing the industry a huge amount of money but it’s costing healthcare providers a lot more.”